236 related articles for article (PubMed ID: 30538246)
1. Single human B cell-derived monoclonal anti-Candida antibodies enhance phagocytosis and protect against disseminated candidiasis.
Rudkin FM; Raziunaite I; Workman H; Essono S; Belmonte R; MacCallum DM; Johnson EM; Silva LM; Palma AS; Feizi T; Jensen A; Erwig LP; Gow NAR
Nat Commun; 2018 Dec; 9(1):5288. PubMed ID: 30538246
[TBL] [Abstract][Full Text] [Related]
2. A monoclonal antibody to Candida albicans enhances mouse neutrophil candidacidal activity.
Caesar-TonThat TC; Cutler JE
Infect Immun; 1997 Dec; 65(12):5354-7. PubMed ID: 9393840
[TBL] [Abstract][Full Text] [Related]
3. Vaccine and monoclonal antibody that enhance mouse resistance to candidiasis.
Xin H; Cutler JE
Clin Vaccine Immunol; 2011 Oct; 18(10):1656-67. PubMed ID: 21832099
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies specific for Candida albicans Als3 that immunolabel fungal cells in vitro and in vivo and block adhesion to host surfaces.
Coleman DA; Oh SH; Zhao X; Zhao H; Hutchins JT; Vernachio JH; Patti JM; Hoyer LL
J Microbiol Methods; 2009 Jul; 78(1):71-8. PubMed ID: 19427882
[TBL] [Abstract][Full Text] [Related]
5. Plant production of anti-β-glucan antibodies for immunotherapy of fungal infections in humans.
Capodicasa C; Chiani P; Bromuro C; De Bernardis F; Catellani M; Palma AS; Liu Y; Feizi T; Cassone A; Benvenuto E; Torosantucci A
Plant Biotechnol J; 2011 Sep; 9(7):776-87. PubMed ID: 21265996
[TBL] [Abstract][Full Text] [Related]
6. Protection by anti-beta-glucan antibodies is associated with restricted beta-1,3 glucan binding specificity and inhibition of fungal growth and adherence.
Torosantucci A; Chiani P; Bromuro C; De Bernardis F; Palma AS; Liu Y; Mignogna G; Maras B; Colone M; Stringaro A; Zamboni S; Feizi T; Cassone A
PLoS One; 2009; 4(4):e5392. PubMed ID: 19399183
[TBL] [Abstract][Full Text] [Related]
7. Complement is essential for protection by an IgM and an IgG3 monoclonal antibody against experimental, hematogenously disseminated candidiasis.
Han Y; Kozel TR; Zhang MX; MacGill RS; Carroll MC; Cutler JE
J Immunol; 2001 Aug; 167(3):1550-7. PubMed ID: 11466376
[TBL] [Abstract][Full Text] [Related]
8. Assessment of Post-Vaccination Phagocytic Activation Using Candida albicans Killing Assays.
Li W; Hu Y
Methods Mol Biol; 2017; 1625():313-326. PubMed ID: 28584999
[TBL] [Abstract][Full Text] [Related]
9. Antibody response that protects against disseminated candidiasis.
Han Y; Cutler JE
Infect Immun; 1995 Jul; 63(7):2714-9. PubMed ID: 7790089
[TBL] [Abstract][Full Text] [Related]
10. Horizontal transmission of Candida albicans and evidence of a vaccine response in mice colonized with the fungus.
Cutler JE; Corti M; Lambert P; Ferris M; Xin H
PLoS One; 2011; 6(7):e22030. PubMed ID: 21818288
[TBL] [Abstract][Full Text] [Related]
11. Defining criteria for anti-mannan antibodies to protect against candidiasis.
Cutler JE
Curr Mol Med; 2005 Jun; 5(4):383-92. PubMed ID: 15977994
[TBL] [Abstract][Full Text] [Related]
12. A fungicidal monoclonal antibody protects against murine invasive candidiasis.
Sevilla MJ; Robledo B; Rementeria A; Moragues MD; Pontón J
Infect Immun; 2006 May; 74(5):3042-5. PubMed ID: 16622248
[TBL] [Abstract][Full Text] [Related]
13. Interplay between protective and inhibitory antibodies dictates the outcome of experimentally disseminated Candidiasis in recipients of a Candida albicans vaccine.
Bromuro C; Torosantucci A; Chiani P; Conti S; Polonelli L; Cassone A
Infect Immun; 2002 Oct; 70(10):5462-70. PubMed ID: 12228271
[TBL] [Abstract][Full Text] [Related]
14. Human gut mycobiota tune immunity via CARD9-dependent induction of anti-fungal IgG antibodies.
Doron I; Leonardi I; Li XV; Fiers WD; Semon A; Bialt-DeCelie M; Migaud M; Gao IH; Lin WY; Kusakabe T; Puel A; Iliev ID
Cell; 2021 Feb; 184(4):1017-1031.e14. PubMed ID: 33548172
[TBL] [Abstract][Full Text] [Related]
15. Comparison of two Candida mannan vaccines: the role of complement in protection against disseminated candidiasis.
Han Y; Rhew KY
Arch Pharm Res; 2012 Nov; 35(11):2021-7. PubMed ID: 23212645
[TBL] [Abstract][Full Text] [Related]
16. Polyclonal anti-Candida antibody improves phagocytosis and overall outcome in zebrafish model of disseminated candidiasis.
Bergeron AC; Barker SE; Brothers KM; Prasad BC; Wheeler RT
Dev Comp Immunol; 2017 Mar; 68():69-78. PubMed ID: 27884707
[TBL] [Abstract][Full Text] [Related]
17. Active immunizations with peptide-DC vaccines and passive transfer with antibodies protect neutropenic mice against disseminated candidiasis.
Xin H
Vaccine; 2016 Jan; 34(2):245-251. PubMed ID: 26620842
[TBL] [Abstract][Full Text] [Related]
18. A monoclonal antibody directed against a Candida albicans cell wall mannoprotein exerts three anti-C. albicans activities.
Moragues MD; Omaetxebarria MJ; Elguezabal N; Sevilla MJ; Conti S; Polonelli L; Pontón J
Infect Immun; 2003 Sep; 71(9):5273-9. PubMed ID: 12933874
[TBL] [Abstract][Full Text] [Related]
19. Increased resistance in BALB/c mice to reinfection with Candida albicans is due to immunoneutralization of a virulence-associated immunomodulatory protein.
Tavares D; Ferreira P; Arala-Chaves M
Microbiology (Reading); 2003 Feb; 149(Pt 2):333-339. PubMed ID: 12624195
[TBL] [Abstract][Full Text] [Related]
20. Active and passive immunization with rHyr1p-N protects mice against hematogenously disseminated candidiasis.
Luo G; Ibrahim AS; French SW; Edwards JE; Fu Y
PLoS One; 2011; 6(10):e25909. PubMed ID: 22028796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
